Biotech firms backs controversial CRISPR challenger – Nature.com
Nature.com |
Biotech firms backs controversial CRISPR challenger
Nature.com A major enzyme manufacturer has signed an agreement with a Chinese university to explore uses for a protein claimed to be a powerful alternative to the popular genome-editing tool CRISPR-Cas9. Several scientists have failed to reproduce the results of … |
